Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Stringent or nonstringent complete remission and prognosis in acute myeloid leukemia: a Danish population-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Mature lymphoid malignancies: origin, stem cells, and chronicity

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Pulmonary Arterial Enlargement in Well-Treated Persons With Human Immunodeficiency Virus

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Characteristics, interventions and longer-term outcomes of COVID-19 ICU patients in Denmark - a nationwide, observational study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Invasive aspergillosis in patients with severe COVID-19 pneumonia

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

Vis graf over relationer

Acute graft-versus-host disease (aGVHD) is a leading cause of transplantation-related mortality after allogeneic hematopoietic stem cell transplantation (aHSCT). 16S ribosomal RNA (16S rRNA) gene-based studies have reported that lower gut bacterial diversity and the relative abundance of certain bacteria after aHSCT are associated with aGVHD. Using shotgun metagenomic sequencing and a large cohort, we aimed to confirm and extend these observations. Adult aHSCT recipients with stool samples collected from day -30 to day 100 relative to aHSCT were included. One sample was selected per patient per period (pre-aHSCT (day -30 to day 0), early post-aHSCT (day 1 to day 28), and late post-aHSCT (day 29 to day 100)), resulting in 150 aHSCT recipients and 259 samples. Microbial and clinical factors were tested for differences between time periods and an association with subsequent aGVHD. Patients showed a decline in gut bacterial diversity posttransplant, with several patients developing a dominance of Enterococcus. A total of 36 recipients developed aGVHD at a median of 34 days (interquartile range, 26-50 days) post-aHSCT. Lower microbial gene richness (P = .02), a lower abundance of the genus Blautia (P = .05), and a lower abundance of Akkermansia muciniphila (P = .01) early post-aHSCT was observed in those who developed aGVHD. Myeloablative conditioning was associated with aGVHD along with a reduction in gene richness and abundance of Blautia and A muciniphila. These results confirm low diversity and Blautia being associated with aGVHD. Crucially, we add that pretransplant conditioning is associated with changes in gut microbiota. Investigations are warranted to determine the interplay of gut microbiota and conditioning in the development of aGVHD.

OriginalsprogEngelsk
TidsskriftBlood advances
Vol/bind4
Udgave nummer22
Sider (fra-til)5797-5809
Antal sider13
ISSN2473-9529
DOI
StatusUdgivet - 24 nov. 2020

Bibliografisk note

© 2020 by The American Society of Hematology.

ID: 61324109